Fulcrum Therapeutics Inc (NAS:FULC)
$ 7.47 -0.03 (-0.4%) Market Cap: 464.29 Mil Enterprise Value: 238.89 Mil PE Ratio: 0 PB Ratio: 1.97 GF Score: 48/100

Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 09:20PM GMT
Release Date Price: $18.28 (-3.94%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

Hi, everyone, and welcome to the final session of the 2021 Crédit Suisse Healthcare Conference. We're excited to have Bryan Stuart, President and CEO; and Chris Morabito, Chief Medical Officer, with us from Fulcrum. If anyone in the audience does have questions, you can certainly send them to me via email, [email protected], and I'll be sure to get those asked on your behalf. But we've got a long list here. So why don't we just jump in?

Questions & Answers

Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst

© -

I thought we could start with a little bit of background on the FulcrumSeek platform, and how it differentiates your discovery process versus competitors?

Bryan E. Stuart
Fulcrum Therapeutics, Inc. - President, CEO & Director

Yes. And Judah, thank you. We appreciate the time. We appreciate everybody tuning in. So Fulcrum was started about 6

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot